Haematogenous seeding in mycosis fungoides and Sézary syndrome: current evidence and clinical implications
Open Access
- 15 November 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 192 (3) , 381-389
Abstract
Cutaneous T-cell lymphomas (CTCLs) are a heterogeneous group of diseases characterized by abnormal neoplastic T-cell growth in the skin. Mycosis fungoides (MF), the most common CTCL, manifests as erythematous skin patches and/or plaques, tumours or erythroderma. The disease may involve blood, lymph nodes and rarely viscera. Sézary syndrome (SS) is a unique leukaemia/lymphoma syndrome related to MF, which presents with blood and skin involvement at diagnosis. The pathogenesis of MF/SS is not fully elucidated. The presence of skin lesions at distant sites underpins a hypothesis that MF/SS lesions may develop through haematogenous seeding. Phenotypic similarities between malignant and normal T cells led to the notion that disease-initiating mutations occur in specific subtypes of mature T cells, which are responsible for most CTCLs. However, this mature T-cell precursor model is not always consistent with clinical observations and research on MF/SS pathogenesis. Here, we review evidence supporting an alternative model of pathogenesis for MF/SS involving haematogenous seeding as a key process responsible for the initiation and progression of the disease. According to this hypothesis, malignant transformation occurs at an early stage of T-cell development (probably in bone marrow or thymus), yielding circulating neoplastic T cells which colonize the skin where the microenvironment is most permissive for proliferation and evolution. These mutated precursor cells seed the skin where they find a suitable niche to develop into clinically perceptible disease. Subsequently, malignant T cells can re-enter the bloodstream, re-seed pre-existing lesions and seed new areas of the skin, causing synchronous and convergent changes in the transcriptomic profile of lesions and tumours, and clinical disease progression – ‘consecutive haematogenous seeding’ captures this temporal phenomenon. This model radically changes the current understanding of CTCL pathogenesis, transforming it from a primarily cutaneous disease with secondary involvement of blood, to a systemic disease, where the spread of malignant cells through the blood to the skin is not a phenomenon of advanced disease but is an essential component of pathogenesis. This understanding of MF/SS could have several clinical implications, including standardizing our approach to assessing blood tumour burden, potential advances in prognosis and monitoring, and investigating combination treatments to improve patient outcomes.Keywords
Funding Information
- Kyowa Kirin International plc
- Swiss Cancer Research Foundation (KFS-4243-08-2017)
- Swiss National Science Foundation (IZLIZ3_200253/1, 320030-232320)
- University of Lausanne (CCP 10-3224-9)
This publication has 97 references indexed in Scilit:
- Association of a Dominant T-Cell Clone in Peripheral Blood With Time to Systemic Treatment in Patients With Stage IB Mycosis FungoidesJAMA Dermatology, 2022
- T-Cell Receptor Gene Rearrangement Clonality, Flow Cytometry Status, and Associated Outcomes in Early-Stage Cutaneous T-Cell LymphomaJAMA Dermatology, 2021
- Antibiotics and Imiquimod for Cutaneous T-Cell Lymphoma in Veterans: A Patient Population with Agent Orange ExposureThe Oncologist, 2021
- Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotypingCytometry Part B: Clinical Cytometry, 2020
- Angioimmunoblastic T‐cell lymphoma contains multiple clonal T‐cell populations derived from a common TET2 mutant progenitor cellThe Journal of Pathology, 2019
- Association of the POT1 Germline Missense Variant p.I78T With Familial MelanomaJAMA Dermatology, 2019
- Naïve/memory T‐cell phenotypes in leukemic cutaneous T‐cell lymphoma: Putative cell of origin overlaps disease classificationCytometry Part B: Clinical Cytometry, 2018
- Altered Nucleus and Disease2018
- Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeoverSeminars in Immunopathology, 2016
- Pitfalls in TCR gene clonality testing: teaching casesJournal of Hematopathology, 2008